Cargando…
Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis
Glioma is the most common primary malignant brain tumors in adults. Despite considerable advances in treatment, the clinical outcome remains dismal. Translocator protein 18 kDa (TSPO), an evolutionarily conserved transmembrane protein, has always been found to be elevated in glioma, which predicts a...
Autores principales: | Wang, Jingya, Ren, Peng, Zeng, Zhirui, Ma, Li, Li, Yunjun, Zhang, Hongmei, Guo, Wenzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208533/ https://www.ncbi.nlm.nih.gov/pubmed/35285415 http://dx.doi.org/10.1080/21655979.2022.2048992 |
Ejemplares similares
-
The 18 kDa Translocator Protein, Microglia and Neuroinflammation
por: Liu, Guo‐Jun, et al.
Publicado: (2014) -
Translocator Protein (18 kDa) Polymorphism (rs6971) in the Korean Population
por: Lee, Hyon, et al.
Publicado: (2022) -
18 kDa Translocator Protein TSPO Is a Mediator of
Astrocyte Reactivity
por: Tournier, Benjamin B., et al.
Publicado: (2023) -
Translocator protein 18 kDa regulates retinal neuron apoptosis and pyroptosis in glaucoma
por: Zeng, Zhou, et al.
Publicado: (2023) -
De novo Neurosteroidogenesis in Human Microglia: Involvement of the 18 kDa Translocator Protein
por: Germelli, Lorenzo, et al.
Publicado: (2021)